{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T14:51:56Z","timestamp":1785595916758,"version":"3.56.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,9]],"date-time":"2025-02-09T00:00:00Z","timestamp":1739059200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency","doi-asserted-by":"publisher","award":["JPMJSP2145"],"award-info":[{"award-number":["JPMJSP2145"]}],"id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological Sciences"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.jphs.2025.02.002","type":"journal-article","created":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T16:21:22Z","timestamp":1739377282000},"page":"212-218","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Neuroprotective effects of compounds interacting with carrier-mediated amantadine transport across the blood\u2013retinal barrier in rats"],"prefix":"10.1016","volume":"157","author":[{"given":"Yusuke","family":"Shinozaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0996-8491","authenticated-orcid":false,"given":"Shin-ichi","family":"Akanuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuma","family":"Tega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken-ichi","family":"Hosoya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jphs.2025.02.002_bib1","doi-asserted-by":"crossref","first-page":"e144","DOI":"10.1016\/S2214-109X(20)30489-7","article-title":"Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study","volume":"9","year":"2021","journal-title":"Lancet Global Health"},{"key":"10.1016\/j.jphs.2025.02.002_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2023.07.028","article-title":"Selective drug delivery to the retinal cells: biological barriers and avenues","volume":"361","author":"Ramsay","year":"2023","journal-title":"J Contr Release"},{"issue":"7","key":"10.1016\/j.jphs.2025.02.002_bib3","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/eye.2013.107","article-title":"Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature","volume":"27","author":"Falavarjani","year":"2013","journal-title":"Eye (Lond)."},{"issue":"8","key":"10.1016\/j.jphs.2025.02.002_bib4","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1016\/j.ophtha.2016.03.045","article-title":"Five-year outcomes with anti-vascular endothelial growth factor treatment of neovascular age-related macular degeneration: the comparison of age-related macular degeneration treatments trials","volume":"123","author":"Maguire","year":"2016","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.jphs.2025.02.002_bib5","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/APO.0000000000000623","article-title":"Novel drug delivery methods and approaches for the treatment of retinal diseases","volume":"12","author":"Ham","year":"2023","journal-title":"Asia Pac J Ophthalmol (Phila)."},{"issue":"4","key":"10.1016\/j.jphs.2025.02.002_bib6","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/febs.16330","article-title":"The blood-retina barrier in health and disease","volume":"290","author":"O'Leary","year":"2023","journal-title":"FEBS J"},{"issue":"9","key":"10.1016\/j.jphs.2025.02.002_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13091339","article-title":"Comprehensive evidence of carrier-mediated distribution of amantadine to the retina across the blood-retinal barrier in rats","volume":"13","author":"Shinozaki","year":"2021","journal-title":"Pharmaceutics"},{"issue":"3","key":"10.1016\/j.jphs.2025.02.002_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/ph16030435","article-title":"The structural characteristics of compounds interacting with the amantadine-sensitive drug transport system at the inner blood-retinal barrier","volume":"16","author":"Shinozaki","year":"2023","journal-title":"Pharmaceuticals (Basel)"},{"issue":"3","key":"10.1016\/j.jphs.2025.02.002_bib9","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s11095-012-0926-y","article-title":"Involvement of a novel organic cation transporter in verapamil transport across the inner blood-retinal barrier","volume":"30","author":"Kubo","year":"2013","journal-title":"Pharm Res"},{"issue":"9","key":"10.1016\/j.jphs.2025.02.002_bib10","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1002\/jps.23535","article-title":"Propranolol transport across the inner blood-retinal barrier: potential involvement of a novel organic cation transporter","volume":"102","author":"Kubo","year":"2013","journal-title":"J Pharmaceut Sci"},{"key":"10.1016\/j.jphs.2025.02.002_bib11","first-page":"91","article-title":"Amantadine and memantine are NMDA receptor antagonists with neuroprotective properties","volume":"43","author":"Kornhuber","year":"1994","journal-title":"J Neural Transm Suppl"},{"key":"10.1016\/j.jphs.2025.02.002_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2023.101225","article-title":"Novel frontiers in neuroprotective therapies in glaucoma: Molecular and clinical aspects","volume":"94","author":"Boccaccini","year":"2023","journal-title":"Mol Aspect Med"},{"issue":"4","key":"10.1016\/j.jphs.2025.02.002_bib13","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1111\/jnc.15122","article-title":"Expression of SOLOIST\/MRTFB i4, a novel neuronal isoform of the mouse serum response factor coactivator myocardin-related transcription factor-B, negatively regulates dendritic complexity in cortical neurons","volume":"159","author":"Ishibashi","year":"2021","journal-title":"J Neurochem"},{"issue":"2","key":"10.1016\/j.jphs.2025.02.002_bib14","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/brb3.118","article-title":"Galantamine potentiates the neuroprotective effect of memantine against NMDA-induced excitotoxicity","volume":"3","author":"Lopes","year":"2013","journal-title":"Brain Behav"},{"issue":"11","key":"10.1016\/j.jphs.2025.02.002_bib15","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1248\/bpb1978.4.879","article-title":"A pharmacokinetic analysis program (multi) for microcomputer","volume":"4","author":"Yamaoka","year":"1981","journal-title":"J Pharmacobio-Dyn"},{"issue":"2","key":"10.1016\/j.jphs.2025.02.002_bib16","first-page":"125","article-title":"Bis(7)-tacrine protects retinal ganglion cells against excitotoxicity via NMDA receptor inhibition","volume":"4","author":"Zhang","year":"2011","journal-title":"Int J Ophthalmol"},{"issue":"3","key":"10.1016\/j.jphs.2025.02.002_bib17","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1167\/iovs.16-21001","article-title":"The relationship between the renin-angiotensin-aldosterone system and NMDA receptor-mediated signal and the prevention of retinal ganglion cell death","volume":"58","author":"Kobayashi","year":"2017","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.jphs.2025.02.002_bib18","article-title":"Molecular mechanisms of NMDA excitotoxicity in the retina. Sci Oct. 2023;13","volume":"13","author":"Dvoriantchikova","year":"2023","journal-title":"Sci Rep"},{"issue":"13","key":"10.1016\/j.jphs.2025.02.002_bib19","doi-asserted-by":"crossref","first-page":"3312","DOI":"10.1523\/JNEUROSCI.4262-04.2005","article-title":"Amantadine inhibits NMDA receptors by accelerating channel closure during channel block","volume":"25","author":"Blanpied","year":"2005","journal-title":"J Neurosci"},{"issue":"1","key":"10.1016\/j.jphs.2025.02.002_bib20","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s12154-009-0029-3","article-title":"Hill coefficients, dose-response curves and allosteric mechanisms","volume":"3","author":"Prinz","year":"2010","journal-title":"J Chem Biol"},{"issue":"1","key":"10.1016\/j.jphs.2025.02.002_bib21","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0026-895X(25)09893-1","article-title":"Hydrophobic interactions of n-alkyl diamines with the N-methyl-D-aspartate receptor: voltage-dependent and -independent blocking sites","volume":"45","author":"Subramaniam","year":"1994","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.jphs.2025.02.002_bib22","series-title":"Registry of Toxic Effects of Chemical Substances (RTECS)","year":"1997"},{"issue":"Suppl 1","key":"10.1016\/j.jphs.2025.02.002_bib23","doi-asserted-by":"crossref","first-page":"S191","DOI":"10.33549\/physiolres.932678","article-title":"Structure, function, and pharmacology of NMDA receptor channels","volume":"63","author":"Vyklicky","year":"2014","journal-title":"Physiol Res"}],"container-title":["Journal of Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S134786132500012X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S134786132500012X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T16:55:25Z","timestamp":1747241725000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S134786132500012X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S134786132500012X"],"URL":"https:\/\/doi.org\/10.1016\/j.jphs.2025.02.002","relation":{},"ISSN":["1347-8613"],"issn-type":[{"value":"1347-8613","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuroprotective effects of compounds interacting with carrier-mediated amantadine transport across the blood\u2013retinal barrier in rats","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jphs.2025.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of Japanese Pharmacological Society.","name":"copyright","label":"Copyright"}]}}